| 摘要 |
FIELD: medicine, endocrinology. ^ SUBSTANCE: the present innovation deals with preventing diabetes mellitus and its aftereffects. It is suggested to apply sibutramin and its analogs to decrease non-susceptibility to insulin in diabetes-free patients, prevent decreased tolerance to glucose and decrease the quantity of introduced insulin in diabetes-suffering patients and normalize body weight, as well. ^ EFFECT: higher efficiency of application. ^ 28 cl, 3 dwg, 1 tbl |
